IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i9p4663-d544726.html
   My bibliography  Save this article

Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018

Author

Listed:
  • Khasan Safaev

    (Republican Specialized Scientific Practical Medical Centre of Phthisiology and Pulmonology under Ministry of Health of the Republic of Uzbekistan, 1 Majlisiy Str., Tashkent 100086, Uzbekistan)

  • Nargiza Parpieva

    (Republican Specialized Scientific Practical Medical Centre of Phthisiology and Pulmonology under Ministry of Health of the Republic of Uzbekistan, 1 Majlisiy Str., Tashkent 100086, Uzbekistan)

  • Irina Liverko

    (Republican Specialized Scientific Practical Medical Centre of Phthisiology and Pulmonology under Ministry of Health of the Republic of Uzbekistan, 1 Majlisiy Str., Tashkent 100086, Uzbekistan)

  • Sharofiddin Yuldashev

    (Republican Specialized Scientific Practical Medical Centre of Phthisiology and Pulmonology under Ministry of Health of the Republic of Uzbekistan, 1 Majlisiy Str., Tashkent 100086, Uzbekistan)

  • Kostyantyn Dumchev

    (The Charitable Organization “Ukrainian Institute on Public Health Policy”, 02000 Kyiv, Ukraine)

  • Jamshid Gadoev

    (World Health Organization Country Office Uzbekistan, 16, M.Tarobiy Str., Tashkent 100100, Uzbekistan)

  • Oleksandr Korotych

    (World Health Organization Regional Office for Europe, UN City, Marmorvej 51, DK-2100 Copenhagen, Denmark)

  • Anthony D. Harries

    (International Union against Tuberculosis and Lung Disease, 68 Boulevard Saint Michel, 75006 Paris, France
    London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK)

Abstract

Uzbekistan has a high burden of drug-resistant tuberculosis (TB). Although conventional treatment for multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) has been available since 2013, there has been no systematic documentation about its use and effectiveness. We therefore documented at national level the trends, characteristics, and outcomes of patients with drug-resistant TB enrolled for treatment from 2013–2018 and assessed risk factors for unfavorable treatment outcomes (death, failure, loss to follow-up, treatment continuation, change to XDR-TB regimen) in patients treated in Tashkent city from 2016–2017. This was a cohort study using secondary aggregate and individual patient data. Between 2013 and 2018, MDR-TB numbers were stable between 2347 and 2653 per annum, while XDR-TB numbers increased from 33 to 433 per annum. At national level, treatment success (cured and treatment completed) for MDR-TB decreased annually from 63% to 57%, while treatment success for XDR-TB increased annually from 24% to 57%. On multivariable analysis, risk factors for unfavorable outcomes, death, and loss to follow-up in drug-resistant TB patients treated in Tashkent city included XDR-TB, male sex, increasing age, previous TB treatment, alcohol abuse, and associated comorbidities (cardiovascular and liver disease, diabetes, and HIV/AIDS). Reasons for these findings and programmatic implications are discussed.

Suggested Citation

  • Khasan Safaev & Nargiza Parpieva & Irina Liverko & Sharofiddin Yuldashev & Kostyantyn Dumchev & Jamshid Gadoev & Oleksandr Korotych & Anthony D. Harries, 2021. "Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018," IJERPH, MDPI, vol. 18(9), pages 1-15, April.
    • Handle: RePEc:gam:jijerp:v:18:y:2021:i:9:p:4663-:d:544726
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/9/4663/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/18/9/4663/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Maeve K Lalor & Jane Greig & Sholpan Allamuratova & Sandy Althomsons & Zinaida Tigay & Atadjan Khaemraev & Kai Braker & Oleksander Telnov & Philipp du Cros, 2013. "Risk Factors Associated with Default from Multi- and Extensively Drug-Resistant Tuberculosis Treatment, Uzbekistan: A Retrospective Cohort Analysis," PLOS ONE, Public Library of Science, vol. 8(11), pages 1-5, November.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Jamshid Gadoev & Damin Asadov & Anthony D. Harries & Ajay M. V. Kumar & Martin Johan Boeree & Araksya Hovhannesyan & Lianne Kuppens & Askar Yedilbayev & Oleksandr Korotych & Atadjan Hamraev & Kallibek, 2021. "Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005–2020), Republic of Karakalpakstan, Uzbekistan," IJERPH, MDPI, vol. 18(23), pages 1-19, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Sizulu Moyo & Helen S Cox & Jennifer Hughes & Johnny Daniels & Leigh Synman & Virginia De Azevedo & Amir Shroufi & Vivian Cox & Gilles van Cutsem, 2015. "Loss from Treatment for Drug Resistant Tuberculosis: Risk Factors and Patient Outcomes in a Community-Based Program in Khayelitsha, South Africa," PLOS ONE, Public Library of Science, vol. 10(3), pages 1-13, March.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:9:p:4663-:d:544726. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.